NEW YORK (GenomeWeb News) — Third Wave Technologies has pocketed $14.9 million after closing the sale of its previously announced zero-coupon convertible notes, the company said today.
 
Third Wave said it intends to use the cash infusion for general corporate expenses.
 
Third Wave said it would place the notes with an unnamed institutional investor on Dec. 19.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.